Life Biosciences, University of Texas-MD Anderson Cancer Center, SBIR, Stanford University, Sloning, MorphoSys, Leibniz-Institut fr Molekulare Pharmakologie, Genentech, City of Hope, TEDCO, Elixir Pharmaceuticals, University of California, Quaker BioVentu | GenomeWeb
Swiss Firm Life Biosciences Inks 10-Year Research Pact with MD Anderson
Swiss bioinformatics firm Life Biosciences said last week that it has entered into a 10-year strategic research agreement with the University of Texas MD Anderson Cancer Center in the area of molecular medicine.
Under the agreement, Life Bio will receive exclusive rights to commercialize intellectual property discovered from joint research projects. Additional financial terms were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.